Demand for Unapproved Weight Loss Drug Surges on Social Media MedPage Today FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling A Retail Explosion of Unapproved Peptides, Research Chemicals, and PEDs The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York